Cognito

Be part of the development of a new device that has the potential to slow the progression of Alzheimer’s disease, from the comfort of home without medications or highly invasive procedures. The objective of this study is to assess the effect of gamma sensory stimulation in individuals with mild/moderate Alzheimer’s Disease on function, cognition and symptoms.

To be eligible for this study, a potential participant must:

  • Be between the ages of 50 and 85
  • Have noticed a change in your memory
  • Have a family member or loved one who can be available as a study partner during the study